Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Tumor-Agnostic 1

Conditions

Lymphoma 9Lymphoma, Large B-Cell, Diffuse 7Lymphoma, Mantle-Cell 5Glioblastoma 5Lymphoma, Non-Hodgkin 4Astrocytoma 4Oligodendroglioma 3Multiple Myeloma 3Gliosarcoma 3Central Nervous System Neoplasms 3Brain Neoplasms 3Neoplasms, Plasma Cell 2Lymphoma, Large-Cell, Immunoblastic 2Hodgkin Disease 2Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasm, Residual 1Neoplasm Metastasis 1Lymphoma, T-Cell, Peripheral 1Lymphoma, T-Cell 1Lymphoma, Large-Cell, Anaplastic 1Lymphoma, Follicular 1Glioma 1Ependymoma 1

Interventions

blinatumomab 2Carboplatin 2venetoclax 1treosulfan 1flumatinib 1fludarabine phosphate 1anlotinib 1aflutinib 1Whole-Body Irradiation 1Tyrosine Kinase Inhibitors 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Maintenance 1Interferon alpha-2 1Inotuzumab Ozogamicin 1Injections 1Immunotherapy 1Drug Therapy 1Docetaxel 1Decitabine 1Cytarabine 1Cyclophosphamide 1Chemotherapy, Adjuvant 1Carmustine 1Busulfan 1Bortezomib 1Blood Specimen Collection 1Azacitidine 1Anti-Inflammatory Agents, Non-Steroidal 1Aminolevulinic Acid 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Unknown × Neoplasm, Residual × Carmustine × Clear all
NCT02670109 2020-01-14

Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment for Triple Negative Breast Cancer Patients

Instituto Nacional de Ciencias Medicas y Nutricion Salvador Zubiran

Phase 2 Unknown
20 enrolled
Tumor-Agnostic

Neoplasm, Residual

Data powered by HemOnc (CC BY 4.0) Colophon âš¡